Ephedra and Ma Huang Consumption: Do the Benefits Outweigh the Risks?

Strength and Conditioning Journal

Volumn 23, Issue 5, 2001, Pages 32-37

  Johnson, Kent D ^a  

^a LIPSCOMB UNIVERSITY   (United States)

Author keywords

Dietary supplements; Ephedra sinica; Ephedrine; Exercise; Ma huang; Pseudoephedrine

Indexed keywords

EID: 0346508876     PISSN: 15241602     EISSN: None     Source Type: Journal    
DOI: 10.1519/1533-4295(2001)023<0032:eamhcd>2.0.co;2     Document Type: Article

References (36)

1. Astrup, A., L. Breum, and S. Toubro. Pharmacological and clinical studies of ephedrine and other thermogenic agonists. Obes. Res. 3(suppl 4):537S-540S. 1995.
2. Astrup, A., L. Breum, S. Toubro, P. Hein, and F. Quaade. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int. J. Obes. 16:269-277. 1992.
3. Astrup, A., L. Breum, S. Toubro, P. Hein, and F. Quaade. Ephedrine and weight loss. Int. J. Obes. 16:715. 1992.
4. Astrup, A., B. Buemann, N. Christensen, S. Toubro, G. Thorbek, O. Victor, and F. Quaade. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism. 41(7):686-688. 1992.
5. Astrup, A., and S. Toubro. Thermogenic, metabolic and cardiovascular responses to ephedrine and caffeine in man. Int. J. Obes. 17:S41-S43. 1993.
6. Astrup, A., S. Toubro, S. Cannon, P. Hein, and J. Madsen. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: A double-blind, placebo-controlled study. Metabolism. 40(3):323-329. 1991.
7. Backer, R., D. Tautman, S. Lowery, C.M. Harvey, and A. Poklis. Fatal ephedrine intoxication. J. Forensic Sci. 42:157-159. 1997.
8. Bell, D.G., and I. Jacobs. Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviat. Space Environ. Med. 70:325-329. 1999.
9. Bell, D.G., I. Jacobs, and J. Zamecink. Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. Eur. J. Appl. Physiol. 77: 427-433. 1998.
10. Betz, J.M., M.L. Gay, M.M. Magdi, S. Adams, and B.S. Portz. Chiral gas Chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Ma Huang. J. Assoc. Off. Anal. Chem. Int. 80:303-315. 1997.
11. Blau, J. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J. Urol. 160(3):825. 1998.
12. Bright, T.P., B.W. Sandage, and H.P. Fletcher. Selected cardiac and metabolic responses to pseudoephedrine with exercise. J. Clin. Pharmacol. 21:488-492. 1981.
13. Clarkson, P., and H. Thompson. Drugs and sport: Research findings and limitations. Sports Med. 24(6): 366-384. 1997.
14. Clemons, J.M., and S.L. Crosby. Cardiopulmonary and subjective effects of a 60 mg dose of pseudoephedrine on graded treadmill exercise. J. Sports Med. Phys. Fitness. 33(4):405-412. 1993.
15. Dietary supplements containing ephedrine alkaloids. Federal Register. 62(7):30677-30724. 1997.
16. Dietary supplements containing ephedrine alkaloids: Availability; reopening of comment period. Federal Register. 65(147): 46721-46722. 2000.
17. Dietary supplements containing ephedrine alkaloids; withdrawal in part. Federal Register. 65(64):17474-17477. 2000.
18. Ephedrine, xanthines, aspirin and other thermogenic drugs to assist the dietary management of obesity. Int. J. Obes. Metab. Disord. 17:Supp:S1-S83. 1993.
19. Flurer, C.L., L.A. Lin, R.D. Satzger, and K.A. Wolnik. Determination of ephedrine compounds in nutritional supplements by cyclodextrin-modified capillary electrophoresis. J. Chromtogr. B. 669:133-139. 1995.
20. Gillies, H., W.E. Perman, T.D. Noakes, P. Smith, A. Evans, and G. Gabriels. Pseudoephedrine is without ergogenic effects during prolonged exercise. J. Appl. Physiol. 81(6):2611-2617. 1996.
21. Gurley, B.J., P. Wang, and S.F. Gardner. Ephedrine-type alkaloid content of nutritional supplements containing ephedra sinica (Ma Huang) as determined by high performance liquid chromatography. J. Pharm. Sci. 87(12):1547-1553. 1998.
22. Jacobs, K.M., and K.A. Hirsch. Psychiatric complications of Ma Huang. Psychosomatics. 41(1):58-62. 2000.
23. King, A.B. The dietary supplement health and education act of 1994: Focus on labeling issues. Nutrition. 13:999-1001. 1997.
24. Lefebure, R.A., F. Surmont, J. Bouckaert, and E. Moerman. Urinary excretion of ephedrine after nasal application in healthy volunteers. J. Pharm. Pharmacol. 44:672-675. 1992.
25. Nadir, A., A. Sangeeta, P.D. King, and J.B. Marshall. Acute hepatitis associated with use of a Chinese herbal product, Ma-Huang. Am. J. Gastroenterol. 91(7):1436-1438. 1996.
26. NCAA News. December 6:7. 1999.
27. Physician Desk Reference (52nd ed.). Montvale, NJ: Medical Economics Company, 1998.
28. Powell, T., F.F. Hsu, J. Turk, and K. Hruska. Ma Huang strikes again: Ephedrine nephrolithiasis. Am. J. Kidney Dis. 32(1):153-159. 1998.
29. Rosene, J.M., J.A. Rosene, D.L. Koczajowski, and V.J. Paolone. Decongestant effects on hemodynamics at rest, exercise, and recovery from exercise during -6° of head down tilt. Aviat. Space Environ. Med. 70:15-21. 1999.
30. Sidney, K.H., and N.M. Lefcoe. The effects of ephedrine on the physiological and psychological response to submaximal and maximal exercise in man. Med. Sci. Sports Exerc. 9:2:95-99. 1977.
31. Swain, R.A., D.M. Harsha, J. Baenziger, and R.M. Saywell. Do pseudoephedrine or phenyl-propanolamine improve maximal oxygen uptake and time to exhaustion? Clin. J. Sport Med. 7(3):168-173. 1997.
32. Tabors Medical Dictionary (18th ed.). Philadelphia: FA Davis Co., 1997.
33. Van der Merwe, P.J., and H.S.L. Kruger. Drugs in sports: Results of the past six years of doping testing in South Africa. S. Afr. Med. J. 82:151-153. 1992.
34. Wagner, J.C. Enhancement of athletic performance with drugs. Sports Med. 12(4): 250-265. 1991.
35. White, L.M., S.F. Gardner, B.J. Gurley, M.A. Marx, P. Wang, and M. Estes. Pharmacokinetics and cardiovascular effects of Ma Huang (ephedra sinica) in normotensive adults. J. Clin. Pharmacol. 37:116-122. 1997.
36. Zaacks, S.M., L. Klein, C.D. Tan, E.R. Rodriguez, and J.B. Leikin. Hypersensitivity myocarditis associated with ephedrine use. J. Toxicol. Clin. Toxicol. 37(4):485-490. 1999.